Latest PARSPORT Results Confirm: IMRT Greatly Reduces Treatment Effects in Head and Neck Cancer

Two-year results from the largest randomized trial of IMRT in head and neck cancer confirm that it dramatically reduces the risk of dysphagia and xerostomia. The study was too small to establish a survival advantage, although the results are encouraging.